Cadence Pharmaceuticals, (FRA:QEW) Debt-to-Revenue : 0.21 (As of Dec. 2013)

Cadence Pharmaceuticals, Debt-to-Revenue Chart

Cadence Pharmaceuticals, Annual Data
	Trend	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
Debt-to-Revenue		Get a 7-Day Free Trial					N/A	N/A	1.72	0.57	0.26

Cadence Pharmaceuticals, Quarterly Data
	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13
Debt-to-Revenue	Get a 7-Day Free Trial															0.42	0.31	0.29	0.25	0.21

Competitive Comparison of Cadence Pharmaceuticals,'s Debt-to-Revenue

For the Biotechnology subindustry, Cadence Pharmaceuticals,'s Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cadence Pharmaceuticals,'s Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cadence Pharmaceuticals,'s Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cadence Pharmaceuticals,'s Debt-to-Revenue falls into.

Cadence Pharmaceuticals, Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Cadence Pharmaceuticals,'s Debt-to-Revenue for the fiscal year that ended in Dec. 2013 is calculated as

Cadence Pharmaceuticals,'s annualized Debt-to-Revenue for the quarter that ended in Dec. 2013 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2013) Revenue data.

Cadence Pharmaceuticals, Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cadence Pharmaceuticals,'s Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cadence Pharmaceuticals, (FRA:QEW) Business Description